Investigation of Human Genome Sciences, Inc. (HGSI)

Zeldes & Haeggquist, LLP has commenced an investigation into Human Genome Sciences, Inc. (NASDAQ: HGSI) to determine whether it has violated securities laws by issuing false and misleading statements to its shareholders between July 20, 2009 and November 11, 2010. We are investigating whether Human Genome issued false and misleading statements during the Class Period…